Singapore markets closed

Straits Times Index
3,130.24
+15.16(+0.49%)
Nikkei
25,937.21
-484.84(-1.83%)
Hang Seng
17,222.83
+56.96(+0.33%)
FTSE 100
6,893.81
+12.22(+0.18%)
BTC-USD
19,151.87
-146.36(-0.76%)
CMC Crypto 200
443.49
+0.06(+0.01%)

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

5.69

+0.09

(+1.61%)

At close: 04:00PM EDT

5.63

-0.06

(-1.05%)

After hours:

07:37PM EDT

Loading interactive chart…

Zacks
Atea (AVIR) Dengue Candidate Gets Fast Track Designation
Atea Pharmaceuticals (AVIR) obtains Fast Track Designation in the United States for AT-752 for the treatment of dengue virus infection.
Motley Fool
Atea Pharmaceuticals, Inc. (AVIR) Q2 2022 Earnings Call Transcript
With me today from Atea are chief executive officer and founder, Dr. Before we begin the call, as outlined on Slide 2, I would like to remind you that today's discussion will contain forward-looking statements that involve risks and uncertainties.
Zacks
Atea Pharmaceuticals, Inc. (AVIR) Upgraded to Strong Buy: What Does It Mean for the Stock?
Atea Pharmaceuticals, Inc. (AVIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).